Vivos Therapeutics (VVOS) Shares Outstanding (2019 - 2025)
Historic Shares Outstanding for Vivos Therapeutics (VVOS) over the last 7 years, with Q3 2025 value amounting to $8.3 million.
- Vivos Therapeutics' Shares Outstanding rose 7348.07% to $8.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 million, marking a year-over-year increase of 7348.07%. This contributed to the annual value of $5.9 million for FY2024, which is 22115.13% up from last year.
- As of Q3 2025, Vivos Therapeutics' Shares Outstanding stood at $8.3 million, which was up 7348.07% from $7.3 million recorded in Q2 2025.
- Vivos Therapeutics' 5-year Shares Outstanding high stood at $23.0 million for Q3 2021, and its period low was $920592.0 during Q4 2021.
- Its 5-year average for Shares Outstanding is $5.9 million, with a median of $2.7 million in 2024.
- Per our database at Business Quant, Vivos Therapeutics' Shares Outstanding tumbled by 9599.95% in 2022 and then surged by 29801.78% in 2024.
- Over the past 5 years, Vivos Therapeutics' Shares Outstanding (Quarter) stood at $920592.0 in 2021, then changed by 0.0% to $920592.0 in 2022, then skyrocketed by 99.21% to $1.8 million in 2023, then surged by 221.15% to $5.9 million in 2024, then skyrocketed by 40.37% to $8.3 million in 2025.
- Its last three reported values are $8.3 million in Q3 2025, $7.3 million for Q2 2025, and $5.9 million during Q1 2025.